Literature DB >> 2221245

Significance of positive margins in oral cavity squamous carcinoma.

T R Loree1, E W Strong.   

Abstract

Three hundred ninety-eight consecutive, previously untreated patients undergoing surgery for epidermoid carcinoma of the oral cavity from 1979 to 1983 were reviewed. One hundred twenty-nine patients were classified as having positive surgical margins. Of these, 83 patients had tumor within 0.5 mm of the surgical margin, 9 had premalignant changes at the margin, 9 had in situ carcinoma at the margin, and 28 had invasive cancer at the margin. The remaining 269 patients had uninvolved margins. The significance of positive margins relating to survival, subsequent clinical course, local recurrence, and patterns of treatment failure was examined, along with the impact of adjuvant postoperative radiotherapy on positive margins. The percentage of patients having positive margins progressively increased with increasing T stage: 21% in T1 versus 55% in T4 primary cancer. The overall 5-year survival for patients with negative margins was 60%. For patients with positive margins, 5-year survival was 52%. This difference was statistically significant. The incidence of local recurrence in patients having positive surgical margins was twice as much as in those with negative margins (36% versus 18%). Metastasis rates in the neck and at distant sites were not significantly influenced by the status of the surgical margin. Of the 129 patients with positive margins, 49 received postoperative radiotherapy. In those patients so treated, a trend toward lower recurrence rates was noted. Differences were not statistically significant. This retrospective review confirms the importance of adequate resection of the primary tumor as well as the relative ineffectiveness of adjuvant postoperative radiotherapy in the improvement of local control in patients with positive surgical margins.

Entities:  

Mesh:

Year:  1990        PMID: 2221245     DOI: 10.1016/s0002-9610(05)80555-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  60 in total

1.  Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.

Authors:  Waseem Jerjes; Tahwinder Upile; Aviva Petrie; Andrew Riskalla; Zaid Hamdoon; Michael Vourvachis; Kostas Karavidas; Amrita Jay; Ann Sandison; Gareth J Thomas; Nicholas Kalavrezos; Colin Hopper
Journal:  Head Neck Oncol       Date:  2010-04-20

Review 2.  Prognostic indicators in head and neck oncology including the new 7th edition of the AJCC staging system.

Authors:  Margaret Brandwein-Gensler; Richard V Smith
Journal:  Head Neck Pathol       Date:  2010-02-06

3.  Intraoperative consultation (IOC) in mucosal lesions of the upper aerodigestive tract.

Authors:  Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2008-07-15

4.  Compartmental Clearance of Infratemporal Fossa for T4b Carcinoma of Buccal Mucosa/Alveolus: Clinical Outcomes.

Authors:  Rakesh Katna; Nikhil Kalyani; Shambhavi Singh; Bharat Bhosale
Journal:  Indian J Surg Oncol       Date:  2020-03-30

5.  Independent Predictors of Prognosis Based on Oral Cavity Squamous Cell Carcinoma Surgical Margins.

Authors:  Marisa R Buchakjian; Timothy Ginader; Kendall K Tasche; Nitin A Pagedar; Brian J Smith; Steven M Sperry
Journal:  Otolaryngol Head Neck Surg       Date:  2018-05-08       Impact factor: 3.497

6.  The histologic risk model is a useful and inexpensive tool to assess risk of recurrence and death in stage I or II squamous cell carcinoma of tongue and floor of mouth.

Authors:  Namita Sinha; Matthew H Rigby; Michael L McNeil; S Mark Taylor; Jonathan Rb Trites; Robert D Hart; Martin J Bullock
Journal:  Mod Pathol       Date:  2018-02-02       Impact factor: 7.842

7.  The role of adjuvant treatment in early-stage oral cavity squamous cell carcinoma: An international collaborative study.

Authors:  Eran Fridman; Shorook Na'ara; Jaiprakash Agarwal; Moran Amit; Gideon Bachar; Andrea Bolzoni Villaret; Jose Brandao; Claudio R Cernea; Pankaj Chaturvedi; Jonathan Clark; Ardalan Ebrahimi; Dan M Fliss; Sashikanth Jonnalagadda; Hugo F Kohler; Luiz P Kowalski; Matthias Kreppel; Chun-Ta Liao; Snehal G Patel; Rajan S Patel; K Thomas Robbins; Jatin P Shah; Thomas Shpitzer; Tzu-Chen Yen; Joachim E Zöller; Ziv Gil
Journal:  Cancer       Date:  2018-05-14       Impact factor: 6.860

8.  Histologic and systemic prognosticators for local control and survival in margin-negative transoral laser microsurgery treated oral cavity squamous cell carcinoma.

Authors:  Parul Sinha; Mitra Mehrad; Rebecca D Chernock; James S Lewis; Samir K El-Mofty; Ningying Wu; Brian Nussenbaum; Bruce H Haughey
Journal:  Head Neck       Date:  2014-01-16       Impact factor: 3.147

Review 9.  The diagnosis and treatment of oral cavity cancer.

Authors:  Klaus-Dietrich Wolff; Markus Follmann; Alexander Nast
Journal:  Dtsch Arztebl Int       Date:  2012-11-30       Impact factor: 5.594

10.  Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age.

Authors:  Marilena Vered; Dan Dayan; Alex Dobriyan; Ran Yahalom; Bruria Shalmon; Iris Barshack; Lev Bedrin; Yoav P Talmi; Shlomo Taicher
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-07       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.